The Fear You Treat in Others

Dr. Miriam Goldstein is 68 and has been a geriatric psychiatrist in Denver for thirty-one years. She has sat across from more than four thousand patients and family members in the specific chair she bought in 1997 because it puts her at eye level with whoever is sitting across from her. She has said the words “cognitive decline” in that chair more times than she can count. She has held the silence that follows those words. She knows the silence. She knows its duration, its texture, the way it breaks. She has been trained to hold it without filling it.

Three months ago, she forgot the name of a medication she has prescribed for twenty years. Not a momentary lapse. A blank. She stood in the hallway outside the exam room, prescription pad in hand, and the name was not there. It came back ninety seconds later. Donepezil. She wrote the prescription. She went back into the room. She did not tell the patient.

She has not told anyone. She is a geriatric psychiatrist who is afraid she is becoming one of her own patients, and she knows exactly what she would tell someone sitting in her chair with this fear. She is not sure the advice holds when the person in the chair is her.

The Fear Before the Fear

#

Before there is a diagnosis, before there is a screening test, before there is a physician’s appointment, there is a feeling. It does not have a clinical name, though Miriam could give it several. It is the experience of noticing something in your own mind that was not there before, or noticing the absence of something that was, and not knowing whether the noticing is accurate or whether it is the particular affliction of a person who knows too much about what cognitive decline looks like.

Miriam’s patients describe it in language she has heard a thousand times. “I’m probably just being paranoid.” “It’s probably nothing.” “My husband says I’m fine.” “I forget things, but doesn’t everyone?” The hedge. The minimization. The appeal to normalcy. She has spent three decades gently moving people past the hedge toward the question that matters: is this something, or is this worry about something?

She cannot move herself past the hedge. She has the clinical vocabulary. She has the diagnostic criteria memorized. She has administered the MoCA to hundreds of patients and knows its limitations better than most neurologists. None of this helps her at 2 AM when she is lying in bed wondering whether the medication name she forgot was a normal age-related retrieval failure or the beginning of something she has spent her career diagnosing in others.

The fear before the fear is the most common psychological experience among adults over 60, and it is the least treated. It is not a diagnosis. It is not a disorder. It is the ambient dread that accompanies aging in a culture that has taught everyone what Alzheimer’s looks like and taught almost no one what normal aging looks like. The gap between those two bodies of knowledge is where the fear lives.

What a Psychiatrist Knows That Does Not Help

#

Miriam knows that subjective cognitive complaints in highly educated professionals are poorly correlated with objective cognitive decline. She knows that the people most likely to notice and report memory changes are often the people least likely to have dementia, because the noticing requires intact self-monitoring capacity, which is among the first things dementia impairs. She knows that anxiety about cognitive decline can itself produce the symptoms it fears: attentional interference from worry reduces working memory performance, which produces the very lapses that feed the worry. She has explained this cycle to patients hundreds of times.

She knows all of this, and it does not help her, because knowing the statistics about subjective cognitive complaints does not answer the question about her specific brain at 2 AM. This is the gap between clinical knowledge and personal experience that every healthcare provider who ages must eventually cross, and it is wider than any textbook suggests.

What Miriam also knows, and what she would tell a patient: the fear itself is not the problem. The fear is a signal. The question is what you do with the signal. You can let it circulate in your chest at 2 AM indefinitely, which costs sleep and produces no information. Or you can convert it into a question that has an answer: make the appointment, get the baseline, establish the longitudinal monitoring from BML-04.02, and let the data replace the dread. The data may confirm the fear. The data may dispel it. Either way, the data is better company than the 2 AM ceiling.

The Psychological Experience of Cognitive Worry

#

Miriam treats this. She treats it every week. The 72-year-old retired engineer who is convinced he has Alzheimer’s because he forgot his grandson’s birthday. The 65-year-old who will not take the screening test because she would rather not know. The couple who cannot talk about it because talking about it makes it real, and so the fear sits between them at dinner like a third person neither of them acknowledges.

The psychological experience of cognitive worry is distinct from the worry itself. It includes shame: the sense that worrying about your mind is self-indulgent, that other people have real problems, that you should be grateful for what you have. It includes isolation: the reluctance to say “I’m afraid I’m losing my mind” to anyone, because saying it aloud grants it a weight the unsaid version does not carry. It includes anticipatory grief, the mourning for a future that may or may not arrive, which BML-04.C1 covers in depth for people who have received a diagnosis but which begins long before the diagnosis, in the years of wondering.

And it includes a specific form of loneliness that Miriam recognizes because she is inside it: the loneliness of a person who knows exactly what to tell others and cannot tell herself. The psychiatrist who treats the fear and has the fear. The cardiologist who prescribes exercise and does not exercise. The oncologist who avoids her own screening. Professional knowledge does not confer personal immunity. It confers a particular kind of suffering: the suffering of knowing exactly what you should do and finding that the knowing does not make the doing any easier.

What the Person With Dementia Feels

#

Miriam’s practice includes patients who have received a diagnosis. She sees them not for the cognitive management, which belongs to the neurologist, but for the psychological experience of living inside a mind that is changing. This is the territory that the rest of Series 04 does not fully enter, and it is the territory this piece opens because the series needs it as a frame.

Depression affects 30 to 50 percent of people with early-stage dementia. It is underdiagnosed because the symptoms of depression and the symptoms of dementia overlap: withdrawal, reduced initiative, sleep disruption, difficulty concentrating, loss of interest. The neurologist sees the cognitive symptoms. The psychiatrist sees the mood symptoms. The person experiences both simultaneously and cannot always tell which is which.

Anxiety is pervasive in early-stage dementia and takes specific forms. The anxiety of anticipation: what will I be like in a year, in two years, in five? The anxiety of exposure: will people see it, will they treat me differently, will I lose my standing? The anxiety of performance: the effort required to maintain normal presentation in social settings is exhausting, and the fear of failing at it in public produces avoidance that looks like withdrawal but is actually self-protection.

These are treatable conditions. Psychotherapy adapted for early cognitive change, shorter sessions, more structured conversations, greater use of written summaries the patient can review between sessions, has evidence for reducing depression and anxiety in early-stage dementia. Antidepressant medication, selected carefully to avoid anticholinergic burden that can worsen cognition, is appropriate for some patients. The combination of adapted psychotherapy and medication produces better outcomes than either alone.

The person with dementia has a psychological life. The series that follows this preface covers detection, drugs, activities, communication, safety, and behavioral management. All of it matters. None of it addresses the experience of the person sitting in Miriam’s chair who says: “I know what is happening to me, and I do not know how to feel about it, and I do not know who to tell that to.” The answer to that question is: a psychiatrist or psychologist who understands cognitive change. They exist. They are underused. They are worth finding.

Miriam Makes the Appointment

#

Miriam makes two appointments. The first is with a neurologist she has referred patients to for fifteen years but has never seen herself. She asks for a cognitive baseline evaluation, the full workup, not the screening she could administer to herself. She wants the data. She is tired of the 2 AM ceiling.

The second appointment is with a colleague. A geriatric psychologist she has co-treated patients with for a decade. She calls her and says: “I need to see you, not as a colleague. As a patient. I need to talk to someone about what I’m afraid of, and I cannot be the someone.” Her colleague says yes without asking why. Miriam suspects she already knows.

She sits in a chair that is not her chair. She is at eye level. She says the thing she has heard four thousand times and has never said: “I’m afraid something is changing, and I don’t know if it’s real.” Her colleague holds the silence. The silence is the right length. The silence breaks when Miriam is ready to continue.

The series that follows this piece covers every tool available for the cognitive journey. Before the tools, there is a person. The person has a mind, and the mind may be changing, and the experience of that possibility is a psychological event that deserves clinical attention, not just clinical screening. The fear is real. The fear is treatable. The person inside the fear is still a person, whether the fear turns out to be warranted or not.

Miriam’s neurologist appointment is next Tuesday. Her therapy appointment is tomorrow at 3. She wrote both on a sticky note and put it on the bathroom mirror, the way she tells her patients to do. She does not know what the neurologist will find. She knows that the sticky note on the mirror is better than the 2 AM ceiling, and that the advice she has given for thirty-one years holds, even when the person taking it is her.